OpenAlex
PricingAboutJobs
Log inGet started
Work

Once-daily sitagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of patients with type 2 diabetes

HTML

Year: 2007
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Current Medical Research and Opinion
DOI: 10.1185/030079907x188152
Authors: Markolf Hanefeld, Gary A. Herman, Mei Wu, Carolyn Mickel, Matilde Sanchez, Peter P. Stein, on behalf of the Sitagliptin Study 014 investigators
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: sitagliptin, DPP-4 inhibitors, type 2 diabetes, once-daily dosing, twice-daily dosing, glycemic control, HbA1c, fasting blood glucose, insulin sensitivity, insulin secretion, hypoglycemia, adverse events, dose-ranging, monotherapy, HOMA-β, QUICKI, HOMA-IR
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2129578585
FWCI: 10.24
Cites: 20
Cited by: 163
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security